Clinical Trial Update: Double Blind Placebo Control Opipramol-Baclofen Treatment for Addiction [EARLY_Phase 1]

View source ↗

Summary

An early-stage, double-blind, placebo-controlled trial is evaluating the combination of opipramol and baclofen for addiction, sponsored by Israel's Ministry of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Substance Use Disorder

Drugs mentioned

• Opipramol-Baclofen (opipramol-baclofen)

Snippet

Sponsor: Ministry of Health, Israel | Conditions: Drug Abuse | EARLY_Phase 1 | Status: UNKNOWN